enVVeno Medical (NVNO) Other Operating Expenses (2021 - 2026)
enVVeno Medical's (NVNO) quarterly Other Operating Expenses came in at -$4000.0 in Q1 2026, down 112.5% quarter-over-quarter from $32000.0 in Q1 2021.
enVVeno Medical (NVNO) Other Operating Expenses (2021 - 2026) Analysis & Trends
enVVeno Medical's Other Operating Expenses history runs 2 years deep, the most recent figure standing at -$4000.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn |
| 10 | enVVeno Medical | 2.75 Mn | 2.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,000.00 |
| Mar 31, 2021 | 32,000.00 |